Cargando…
Issues and current applications of interspecies extrapolation of carcinogenic potency as a component of risk assessment.
The Life Sciences Research Office (LSRO) of the Federation of American Societies for Experimental Biology (FASEB) is conducting this symposium under contract with the Center for Food Safety and Applied Nutrition (CFSAN) of the Food and Drug Administration (FDA). The FDA has requested information on...
Autor principal: | Visek, W J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474529/ https://www.ncbi.nlm.nih.gov/pubmed/3289907 |
Ejemplares similares
-
Uncertainties in interspecies extrapolations of carcinogenicity.
por: Crouch, E A
Publicado: (1983) -
Needs for biological risk assessment in interspecies extrapolation.
por: Clayson, D B
Publicado: (1988) -
Opportunities for improving techniques for interspecies extrapolation in the risk assessment process.
por: Gibson, J E, et al.
Publicado: (1988) -
Interspecies extrapolation by physiologically based pharmacokinetic modeling
por: Ghallab, Ahmed
Publicado: (2015) -
Interspecies extrapolation in carcinogenesis: prediction between rats and mice.
por: Gold, L S, et al.
Publicado: (1989)